1. Home
  2. DMA vs DRIO Comparison

DMA vs DRIO Comparison

Compare DMA & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Destra Multi-Alternative Fund

DMA

Destra Multi-Alternative Fund

HOLD

Current Price

$7.44

Market Cap

66.5M

Sector

Finance

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.34

Market Cap

60.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DMA
DRIO
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.5M
60.6M
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
DMA
DRIO
Price
$7.44
$6.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$35.00
AVG Volume (30 Days)
19.4K
6.9K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.25
Revenue
N/A
$7,394,000.00
Revenue This Year
N/A
$20.27
Revenue Next Year
N/A
$47.58
P/E Ratio
N/A
$4.79
Revenue Growth
N/A
43.02
52 Week Low
$6.94
$0.38
52 Week High
$9.15
$17.74

Technical Indicators

Market Signals
Indicator
DMA
DRIO
Relative Strength Index (RSI) 45.37 28.03
Support Level $7.27 N/A
Resistance Level $7.74 $9.46
Average True Range (ATR) 0.15 0.39
MACD -0.01 -0.13
Stochastic Oscillator 27.48 16.76

Price Performance

Historical Comparison
DMA
DRIO

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income, with an emphasis on income generation. The Fund pursues its investment objective by investing mainly in the income-producing securities of real estate investment trusts (REITs) and alternative investment funds, as well as common stocks and structured notes, bonds, and asset-backed securities.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: